ClinicalTrials.gg
Sign In

Carcinoma, Medullary clinical trials

The registry lists 144 studies for Carcinoma, Medullary across more than 10 countries. 30 are recruiting or about to start. 64 of them are mainly about Carcinoma, Medullary (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Carcinoma, Medullary studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
66
Active, not recruiting
17
Recruiting
16
Terminated
12
Not yet recruiting
11
Status unknown
9

Phase

Phase 2
53
Phase 1
42
Phase 3
9
Phase 4
4
Early Phase 1
1

Where

United States
81
Italy
19
China
18
France
17
Spain
15
Canada
15

Who runs them

National Cancer Institute (NCI) (20) · M.D. Anderson Cancer Center (8) · Genzyme, a Sanofi Company (6) · Exelixis (4) · Eli Lilly and Company (4) · Sanofi (3) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (3) · European Organisation for Research and Treatment of Cancer - EORTC (3)

What is being tested here

Drugs under test in Carcinoma, Medullary studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Anlotinib112
Lutetium Lu 177 dotatate102
Enfortumab vedotin101
AMG 757101
Gallium Ga 68 dotatate101
Catequentinib hydrochloride101
Cabozantinib018
Vandetanib018
Selpercatinib015
Sorafenib005

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open · Alkylating agents 5 · Antimetabolites 4 · mTOR inhibitors 4 · Angiogenesis inhibitors 3

Coming up

2phase 3 studies under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 16 Carcinoma, Medullary studies recruiting now, 9 (56%) set no upper age limit and 3 (19%) stop at 75 or younger. 3 (19%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (19%) take healthy volunteers.

Recruiting studies that take each age, of 16
AgeWomenMen
103 (19%)3 (19%)
1816 (100%)16 (100%)
3016 (100%)16 (100%)
4016 (100%)16 (100%)
5016 (100%)16 (100%)
6516 (100%)16 (100%)
7516 (100%)16 (100%)
8512 (75%)12 (75%)

Across all 144 studies, recruiting or not: 8% stop at 75 or younger and 6% at 65; 17% take children; 0% are for women only and 0% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 144. Browse all 144 → or search them.